Dr. Lal PathLabs Ltd

NSE:LALPATHLAB (India)  
₹ 2798.30 (+1.58%) Jun 7
65.11
P/B:
12.59
Market Cap:
₹ 232.86B ($ 2.79B)
Enterprise V:
₹ 225.91B ($ 2.71B)
Volume:
216.05K
Avg Vol (2M):
292.97K
Volume:
216.05K
Avg Vol (2M):
292.97K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Dr. Lal PathLabs Ltd ( ) from 2015 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Dr. Lal PathLabs stock (NSE:LALPATHLAB) PE ratio as of Jun 10 2024 is 65.11. More Details

Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) PE Ratio (TTM) Chart

To

Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) PE Ratio (TTM) Historical Data

Total 1295
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Dr. Lal PathLabs PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-10 65.1 2024-04-09 53.3
2024-06-07 65.1 2024-04-08 53.3
2024-06-06 64.1 2024-04-05 53.1
2024-06-05 64.6 2024-04-04 53.0
2024-06-04 61.5 2024-04-03 53.3
2024-06-03 62.2 2024-04-02 53.0
2024-05-31 61.6 2024-04-01 53.2
2024-05-30 61.1 2024-03-29 52.6
2024-05-29 61.8 2024-03-28 52.6
2024-05-28 60.9 2024-03-27 57.4
2024-05-27 61.3 2024-03-26 57.2
2024-05-24 61.1 2024-03-25 53.7
2024-05-23 60.1 2024-03-22 53.7
2024-05-22 60.2 2024-03-21 52.4
2024-05-21 59.5 2024-03-20 51.6
2024-05-20 59.3 2024-03-19 50.8
2024-05-18 59.0 2024-03-18 50.8
2024-05-17 59.3 2024-03-15 51.0
2024-05-16 58.7 2024-03-14 51.8
2024-05-15 57.5 2024-03-13 50.8
2024-05-14 58.0 2024-03-12 52.8
2024-05-13 58.0 2024-03-11 54.1
2024-05-10 54.6 2024-03-08 55.0
2024-05-09 51.9 2024-03-07 55.0
2024-05-08 54.2 2024-03-06 55.4
2024-05-07 54.0 2024-03-05 56.5
2024-05-06 54.4 2024-03-04 57.4
2024-05-03 53.9 2024-03-01 58.8
2024-05-02 54.7 2024-02-29 59.3
2024-05-01 55.2 2024-02-28 58.4
2024-04-30 55.2 2024-02-27 59.8
2024-04-29 54.6 2024-02-26 61.0
2024-04-26 55.6 2024-02-23 61.8
2024-04-25 54.2 2024-02-22 61.7
2024-04-24 54.2 2024-02-21 61.3
2024-04-23 52.3 2024-02-20 62.4
2024-04-22 52.6 2024-02-19 63.1
2024-04-19 51.4 2024-02-16 62.4
2024-04-18 52.2 2024-02-15 61.4
2024-04-17 54.1 2024-02-14 61.9
2024-04-16 54.1 2024-02-13 62.5
2024-04-15 54.0 2024-02-12 62.0
2024-04-12 54.9 2024-02-09 61.9
2024-04-11 53.6 2024-02-08 61.0
2024-04-10 53.6 2024-02-07 63.1

Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.